101 related articles for article (PubMed ID: 2265403)
1. Translocation (3;21) in a patient with secondary hematological malignancy.
Aventín A; Brunet S; de Andrés L; Bordes R; Moltó E; Domingo A; Pujol-Moix N
Cancer Genet Cytogenet; 1990 Dec; 50(2):227-9. PubMed ID: 2265403
[No Abstract] [Full Text] [Related]
2. Chronic myelomonocytic leukemia with t(1;3)(p36;q21) and a synchronous gastric cancer.
Fujisawa S; Harano H; Yamazaki E; Motomura S; Mohri H; Ishigatsubo Y
Am J Med Sci; 2000 Apr; 319(4):258-60. PubMed ID: 10768613
[TBL] [Abstract][Full Text] [Related]
3. Secondary chronic myelomonocytic leukemia with t(9;11) in a child.
George R; Pearson AD; Evans J; Reid MM
Cancer Genet Cytogenet; 1994 Jul; 75(1):64-6. PubMed ID: 8039167
[TBL] [Abstract][Full Text] [Related]
4. [Double t (3; 21) in acute myelomonocytic leukemia transformed from chronic myelomonocytic leukemia].
Arai Y; Handa T; Nakamura F; Takahashi W; Maki K; Mitani K
Rinsho Ketsueki; 2002 Sep; 43(9):865-7. PubMed ID: 12412294
[TBL] [Abstract][Full Text] [Related]
5. 8;21 translocation with duplication of the der(21) in a patient with myelomonocytic leukemia.
Auger MJ; Ross FM; Mackie MJ
Cancer Genet Cytogenet; 1991 Jan; 51(1):139-41. PubMed ID: 1984844
[TBL] [Abstract][Full Text] [Related]
6. INV(12) (p13q11) and dicentric chromosomes in a secondary leukaemia with basophilia.
Huret JL; Brizard A; Guilhot F; Couet D; Schoenwald M; Savage JR; Tanzer J
Haematologica; 1990; 75(5):473-6. PubMed ID: 2129034
[TBL] [Abstract][Full Text] [Related]
7. A new translocation, t(3;6)(q12;24) associated with chronic myelomonocytic leukaemia and marrow fibrosis.
Krishnan K; Sheldon S
Clin Lab Haematol; 1996 Mar; 18(1):47-9. PubMed ID: 9118605
[TBL] [Abstract][Full Text] [Related]
8. Secondary chronic myelomonocytic leukemia with monosomy 7 after successful treatment of acute promyelocytic leukemia.
Jeddi R; Gouider E; Benneji H; Mnif S; Ben Abid H; Belhadjali Z; Meddeb B
Pathol Biol (Paris); 2008 May; 56(3):162-3. PubMed ID: 18178033
[TBL] [Abstract][Full Text] [Related]
9. Therapy-related chronic myelomonocytic leukemia with unique chromosomal abnormalities: monosomy 7 and t(12;17)(p13;q11.2).
Oo TH; Kenney L
Am J Hematol; 2007 Mar; 82(3):248-9. PubMed ID: 16924641
[No Abstract] [Full Text] [Related]
10. AML1/RUNX1 fusion gene and t(5;21)(q13;q22) in a case of chronic myelomonocytic leukemia with progressive thrombocytopenia and monocytosis.
Liu S; Li C; Bo L; Dai Y; Xiao Z; Wang J
Cancer Genet Cytogenet; 2004 Jul; 152(2):172-4. PubMed ID: 15262442
[No Abstract] [Full Text] [Related]
11. Chronic myelomonocytic leukemia with a novel t(5;18) translocation.
Wong KF; Chu Y; Chung J
Cancer Genet Cytogenet; 1995 Nov; 85(1):89. PubMed ID: 8536248
[No Abstract] [Full Text] [Related]
12. [Acute transformation of chronic myelomonocytic leukemia with t(1;3) (p36;q21) abnormality].
Onishi Y; Nakamichi T; Maeda Y; Chinzei T; Nakagawa T; Saigo K
Rinsho Ketsueki; 1998 Jul; 39(7):519-25. PubMed ID: 9750460
[TBL] [Abstract][Full Text] [Related]
13. Atypical chronic myelomonocytic leukemia with eosinophilia and translocation (5;12). A new association.
Berkowicz M; Rosner E; Rechavi G; Mamon Z; Neuman Y; Ben-Bassat I; Ramot B
Cancer Genet Cytogenet; 1991 Feb; 51(2):277-8. PubMed ID: 1993313
[No Abstract] [Full Text] [Related]
14. Chronic myelomonocytic leukemia with t(13;14) in a child.
Bown N; Yule SM; Evans J; Kernahan J; Reid MM
Cancer Genet Cytogenet; 1992 Jun; 60(2):190-2. PubMed ID: 1606563
[TBL] [Abstract][Full Text] [Related]
15. Translocation (1;3)(p36;q21) in secondary leukemia.
Panani AD; Ferti-Passantonopoulou A; Economopoulos T; Raptis S
Cancer Genet Cytogenet; 1990 Nov; 50(1):165-7. PubMed ID: 2253185
[TBL] [Abstract][Full Text] [Related]
16. Translocation t(9;11)(p21;q23) with acute myelomonocytic leukemia after chemotherapy for osteosarcoma: good response to antileukemic drugs.
Fenaux P; Jouet JP; Bauters F; Lai JL; Lepelley P
J Clin Oncol; 1987 Aug; 5(8):1304-5. PubMed ID: 2442320
[No Abstract] [Full Text] [Related]
17. Systemic mastocytosis with associated clonal hematological non-mast-cell lineage disease: analysis of clinicopathologic features and activating c-kit mutations.
Pullarkat VA; Bueso-Ramos C; Lai R; Kroft S; Wilson CS; Pullarkat ST; Bu X; Thein M; Lee M; Brynes RK
Am J Hematol; 2003 May; 73(1):12-7. PubMed ID: 12701114
[TBL] [Abstract][Full Text] [Related]
18. Sustained response to low-dose imatinib mesylate in a patient with chronic myelomonocytic leukemia with t(5;12)(q33;p13).
Shin J; Kim M; Kim DB; Yeom JO; Lee HJ; Cho SG
Acta Haematol; 2008; 119(1):57-9. PubMed ID: 18268406
[No Abstract] [Full Text] [Related]
19. der(5;17)(p10;q10) is a recurrent but rare whole-arm translocation in patients with hematological neoplasms: a report of three cases.
Manabe M; Okita J; Tarakuwa T; Harada N; Aoyama Y; Kumura T; Ohta T; Furukawa Y; Mugitani A
Acta Haematol; 2014; 132(2):134-9. PubMed ID: 24556628
[TBL] [Abstract][Full Text] [Related]
20. Inclusion of secondary chronic myelomonocytic leukemia and myeloproliferative disease, unclassifiable, in classification of pediatric myeloproliferative disorders.
Occhipinti E; Correa H; Yu L; Craver R
J Pediatr Hematol Oncol; 2006 Oct; 28(10):700-1. PubMed ID: 17023836
[No Abstract] [Full Text] [Related]
[Next] [New Search]
